NCT04426695View on ClinicalTrials.gov

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

2,252

Participants

Timeline

Start Date

June 10, 2020

Primary Completion Date

May 7, 2021

Study Completion Date

October 22, 2021

Conditions
COVID-19
Interventions
DRUG

REGN10933+REGN10987 combination therapy

Administered intravenously (IV) single dose

DRUG

Placebo

Placebo IV Single Dose

Trial Locations (123)

10003

Regeneron Study Site, New York

10019

Regeneron Study Site, New York

10025

Regeneron Study Site, New York

10029

Regeneron Study Site, New York

10032

Regeneron Study Site, New York

10037

Regeneron Study Site, New York

10451

Regeneron Study Site, The Bronx

10461

Regeneron Study Site, The Bronx

10601

Regeneron Study Site, White Plains

11219

Regeneron Study Site, Brooklyn

11432

Regeneron Study Site, Jamaica

11795

Regeneron Study Site, West Islip

13210

Regeneron Study Site, Syracuse

14203

Regeneron Study Site, Buffalo

14215

Regeneron Study Site 1, Buffalo

Regeneron Study Site 2, Buffalo

14642

Regeneron Study Site, Rochester

19140

Regeneron Study Site, Philadelphia

21201

Regeneron Study Site, Baltimore

23298

Regeneron Study Site, Richmond

27408

Regeneron Study Site, Greensboro

27599

Regeneron Study Site, Chapel Hill

30060

Regeneron Study Site, Marietta

30309

Regeneron Study Site, Atlanta

30322

Regeneron Study Site, Atlanta

30912

Regeneron Study Site, Augusta

32504

Regeneron Study Site, Pensacola

32610

Regeneron Study Site, Gainesville

32803

Regeneron Study Site, Orlando

33486

Regeneron Study Site, Boca Raton

33612

Regeneron Study Site, Tampa

34239

Regeneron Study Site, Sarasota

34982

Regeneron Study Site, Ft. Pierce

35249

Regeneron Study Site, Birmingham

40202

Regeneron Study Site, Louisville

40217

Regeneron Study Site, Louisville

43210

Regeneron Study Site, Columbus

43215

Regeneron Study Site, Columbus

44340

Regeneron Study Site, Guadalajara

45170

Regeneron Study Site, Zapopan

45409

Regeneron Study Site, Dayton

46260

Regeneron Study Site, Indianapolis

48073

Regeneron Study Site, Royal Oak

49503

Regeneron Study Site, Grand Rapids

52242

Regeneron Study Site, Iowa City

53792

Regeneron Study Site, Madison

55905

Regeneron Study Site, Rochester

57108

Regeneron Study Site, Sioux Falls

60026

Regeneron Study Site, Glenview

60611

Regeneron Study Site, Chicago

60612

Regeneron Study Site, Chicago

61801

Regeneron Study Site, Urbana

63017

Regeneron Study Site, Chesterfield

63104

Regeneron Study Site, St Louis

63110

Regeneron Study Site, St Louis

64060

Regeneron Study Site, Monterrey

64718

Regeneron Study Site, Monterrey

70112

Regeneron Study Site, New Orleans

70122

Regeneron Study Site, New Orleans

75235

Regeneron Study Site, Dallas

75246

Regeneron Study Site, Dallas

75390

Regeneron Study Site, Dallas

75701

Regeneron Study Site, Tyler

77004

Regeneron Study Site, Houston

77024

Regeneron Study Site, Houston

77030

Regeneron Study Site, Houston

77479

Regeneron Study Site, Sugar Land

79106

Regeneron Study Site 1, Amarillo

Regeneron Study Site 2, Amarillo

79410

Regeneron Study Site, Lubbock

80020

Regeneron Study Site, Culiacán

80045

Regeneron Study Site, Aurora

80230

Regeneron Study Site, Culiacán

84107

Regeneron Study Site, Murray

84143

Regeneron Study Site, Salt Lake City

85006

Regeneron Study Site, Phoenix

85224

Regeneron Study Site, Chandler

85724

Regeneron Study Site 1, Tucson

87108

Regeneron Study Site, Albuquerque

89109

Regeneron Study Site, Las Vegas

90404

Regeneron Study Site, Santa Monica

90806

Regeneron Study Site, Long Beach

91345

Regeneron Study Site, Mission Hills

91700

Regeneron Study Site, Veracruz

94305

Regeneron Study Site, Stanford

95817

Regeneron Study Site, Sacramento

97000

Regeneron Study Site 1, Mérida

Regeneron Study Site 2, Mérida

97213

Regeneron Study Site, Portland

97239

Regeneron Study Site, Portland

98122

Regeneron Study Site 1, Seattle

98201

Regeneron Study Site, Everett

7500691

Regeneron Study Site, Santiago

7591047

Regeneron Study Site 1, Las Condes

Regeneron Study Site 2, Las Condes

7650568

Regeneron Study Site, Vitacura

02111

Regeneron Study Site, Boston

02115

Regeneron Study Site, Boston

02118

Regeneron Study Site, Boston

68198-5400

Regeneron Study Site, Omaha

07631

Regeneron Study Site, Englewood

07601

Regeneron Study Site, Hackensack

07960

Regeneron Study Site, Morristown

07753

Regeneron Study Site, Neptune City

08534

Regeneron Study Site, Pennington

07901

Regeneron Study Site, Summit

07666

Regeneron Study Site, Teaneck

02903

Regeneron Study Site, Providence

02906

Regeneron Study Site, Providence

60160-230

Regeneron Study Site, Fortaleza

40170-130

Regeneron Study Site, Salvador

80810-040

Regeneron Study Site, Curitiba

99010-170

Regeneron Study Site, Passo Fundo

90610-000

Regeneron Study Site, Porto Alegre

89801-355

Regeneron Study Site, Chapecó

88811-508

Regeneron Study Site, Criciúma

18618-686

Regeneron Study Site, Botucatu

13060-080

Regeneron Study Site, Campinas

02401- 400

Regeneron Study Site, São Paulo

04012-909

Regeneron Study Site, São Paulo

05403-010

Regeneron Study Site, São Paulo

MD-2025

Regeneron Study Site, Chisinau

021105

Regeneron Study Site, Bucharest

All Listed Sponsors
lead

Regeneron Pharmaceuticals

INDUSTRY

NCT04426695 - Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19 | Biotech Hunter | Biotech Hunter